Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F Carlquist

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Journal of the American College of Cardiology|April 3, 1998
Angiotensin-converting enzyme genotypes and risk for myocardial infarction in womenJ L Anderson, J F Carlquist, G J King, et al.
Circulation|October 12, 2000
Randomized secondary prevention trial of azithromycin in patients with coronary artery disease: primary clinical results of the ACADEMIC studyJ B Muhlestein, J L Anderson, J F Carlquist, et al.
Clinical Pharmacology and Therapeutics|April 9, 2010
Integration of genetic, clinical, and INR data to refine warfarin dosingP Lenzini, M Wadelius, S Kimmel, et al.
Clinical Pharmacology and Therapeutics|November 8, 2012
Impact of the CYP4F2 p.V433M polymorphism on coumarin dose requirement: systematic review and meta-analysisE Danese, M Montagnana, J A Johnson, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Journal of the American College of Cardiology|April 3, 1998
Angiotensin-converting enzyme genotypes and risk for myocardial infarction in womenJ L Anderson, J F Carlquist, G J King, et al.
Circulation|October 12, 2000
Randomized secondary prevention trial of azithromycin in patients with coronary artery disease: primary clinical results of the ACADEMIC studyJ B Muhlestein, J L Anderson, J F Carlquist, et al.
Clinical Pharmacology and Therapeutics|April 9, 2010
Integration of genetic, clinical, and INR data to refine warfarin dosingP Lenzini, M Wadelius, S Kimmel, et al.
Clinical Pharmacology and Therapeutics|November 8, 2012
Impact of the CYP4F2 p.V433M polymorphism on coumarin dose requirement: systematic review and meta-analysisE Danese, M Montagnana, J A Johnson, et al.
Pageof 5